Sign In
Buy MTSR
$70.50
+0 (+0%)
At Close: Feb 12, 2026
Wall Street Brunch: Here Come The 13Fs
01:31pm, Sunday, 09'th Nov 2025
13F filings this week will reveal hedge fund and institutional moves, offering insight into smart money positioning amid recent market highs. Earnings season is winding down, with 90% of S&P 500 compa
Novo Nordisk will not increase its proposal to acquire Metsera, Inc.
03:19am, Saturday, 08'th Nov 2025
Bagsværd, Denmark, 8 November 2025 – Novo Nordisk today confirms that it does not intend to make an increased offer to acquire Metsera. On 30 October 2025, Novo Nordisk announced the submission
Pfizer prevails over rival Novo Nordisk after an unusual bidding war for the weight-loss startup.
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
09:32pm, Friday, 07'th Nov 2025
Revised transaction values Metsera at up to $86.25 per share Metsera's Board of Directors unanimously recommends that Metsera stockholders approve the adoption of the amended Pfizer merger agreement
Pfizer sweetens offer for Metsera in bidding war against Novo, Bloomberg News reports
07:59pm, Friday, 07'th Nov 2025
Pfizer has submitted a sweetened bid for obesity drug developer Metsera , as its fight against rival Novo Nordisk escalates, Bloomberg News reported on Friday.
Novo CEO says its bid for Metsera is higher
02:23pm, Thursday, 06'th Nov 2025
Novo Nordisk CEO Mike Doustdar said during a White House event on Thursday that the company's bid for obesity biotech Metsera is higher than the one from rival Pfizer Inc. , which has sued both Metser
What is Metsera, the target in Pfizer's and Novo Nordisk's bidding war?
12:01pm, Thursday, 06'th Nov 2025
Pfizer and Novo Nordisk are locked in a bidding war for biotech firm Metsera as the pharmaceutical giants seek to augment their pipeline in the booming weight-loss drug market.
Pfizer To Raise Metsera Bid After Court Denies Attempt To Block Rival Deal
11:40am, Thursday, 06'th Nov 2025
The Delaware Chancery Court denied Pfizer Inc.'s (NYSE:PFE) request for a temporary restraining order to prevent Metsera, Inc. (NASDAQ:MTSR) from terminating the existing merger agreement in favor o
'It's Getting Ugly,' Analyst Says As Pfizer Escalates Its Gloves-Off Fight For Metsera
10:11am, Thursday, 06'th Nov 2025
Metsera stock surged Thursday on reports Pfizer has matched Novo Nordisk's $10 billion bid to buy the obesity-focused biotech.
Metsera weighs rival bids from Pfizer, Novo in $10 billion obesity drug battle
08:49am, Thursday, 06'th Nov 2025
A bidding war over U.S. biotech Metsera was coming to a head on Thursday, with Danish drugmaker Novo Nordisk locked in a $10 billion battle with U.S. rival Pfizer to win Metsera's obesity drug assets.
Wall Street Breakfast Podcast: Government Shutdown Hits New Altitude
06:29am, Thursday, 06'th Nov 2025
FAA will reduce air traffic by 10% across 40 major markets due to staffing shortages from the government shutdown, impacting 3,500-4,000 flights daily. Pfizer (PFE) has matched Novo Nordisk's bid for
Metsera Issues Statement in Response to Litigation Ruling
07:17pm, Wednesday, 05'th Nov 2025
NEW YORK , Nov. 5, 2025 /PRNewswire/ -- Metsera, Inc. (NASDAQ: MTSR) ("Metsera" or the "Company") today issued the following statement in response to a ruling in the litigation filed against the Compa
Expect Pfizer bid to beat Novo for Metsera, says BMO's Evan David Seigerman
06:02pm, Wednesday, 05'th Nov 2025
Evan David Seigerman, BMO, joins 'Fast Money' to talk bidding wars in the pharma space, Novo Nordisk dropping on earnings, and more.
Pfizer preparing to raise its bid for Metsera, WSJ reports
05:02pm, Wednesday, 05'th Nov 2025
Pfizer is preparing to sweeten its offer again for Metsera , the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
Pfizer is preparing to sweeten its offer again for Metsera, the weight-loss drug startup at the center of a bidding war that also involves Novo Nordisk.
